FindTrial
Sign In

Fractional Exhaled Nitric Oxide (FeNO)

DEVICE3 trials

Sponsors

AstraZeneca, Franciscus Gasthuis, University of Nottingham

Conditions

AsthmaAsthma AttackCOPDChronic Obstructive Pulmonary Disease

Unknown Phase

Observational Study of Obstructive Lung Disease (NOVELTY)
CompletedNCT02760329
AstraZenecaAsthma, Chronic Obstructive Pulmonary Disease, COPD
Start: 2016-07-25End: 2023-05-31Updated: 2024-10-03
Phenotyping and Classifying Asthma Exacerbations
Active, not recruitingNCT05304039
Franciscus GasthuisAsthma Attack
Start: 2022-09-28End: 2025-12-31Target: 200Updated: 2025-08-21
Asthma: Phenotyping Exacerbations 3
NCT05446090
University of NottinghamAsthma Attack
Start: 2022-05-09End: 2023-12-31Target: 100Updated: 2022-07-06

Related Papers

Filling the Gaps in Health Data: Using a Machine Learning Approach to Augment Partially Observed Variables Such as Smoking in Claims Data
Pharmacoepidemiology and Drug Safety2026-01-29
Prevalence and Clinical Characteristics of Persistent Airflow Limitation in the NOVELTY Cohort
Annals of the American Thoracic Society2025-09-172 citations
Validity of the Chronic Airways Assessment Test (CAAT) in asthma, asthma+COPD and COPD in NOVELTY.
2025-07-21
Mapping EQ-5D-5L Score From SGRQ in Patients with Asthma and/or COPD in NOVELTY.
2025-06-04
The effect of a systematic multi-dimensional assessment in severe uncontrolled asthma: a literature review and protocol for an investigator-initiated, open-label, randomized-controlled trial (EXACT@home study).
2025-05-17
Type-2 and Allergic Biomarkers in Asthma and/or COPD in the NOVELTY Study
American Journal of Respiratory and Critical Care Medicine2025-05-01
The Pulmonary Health Index (PHI): A Novel Composite Indicator of Lung Health Status in Patients With Asthma or COPD
American Journal of Respiratory and Critical Care Medicine2025-05-01
Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY
Therapeutic Advances in Respiratory Disease2024-01-0110 citations
Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers.
2023-12-227 citations
The many faces of COPD in real life: a longitudinal analysis of the NOVELTY cohort
ERJ Open Research2023-12-2116 citations
Phenotyping the Responses to Systemic Corticosteroids in the Management of Asthma Attacks (PRISMA): protocol for an observational and translational pilot study
BMJ Open Respiratory Research2023-11-018 citations
P177 129Xe MRI phenotyping and longitudinal change in patients with asthma and/or COPD and normal pulmonary function tests
2023-11-01
P176 Bronchodilator response discordance in patients with asthma and/or COPD assessed by 129Xe-MRI and spirometry
2023-11-01
Bronchodilator response discordance in patients with asthma and/or COPD using Xe-MRI and spirometry
2023-09-092 citations
Late Breaking Abstract - Frequent Productive Cough associates with an increased risk of cardiopulmonary outcomes in a real-life cohort of patients with COPD (NOVELTY study)
2023-09-091 citations
Xe-MRI bronchodilator response to assess disease severity in patients with asthma and/or COPD
2023-09-09
Longitudinal change in lung physiology and 129Xe MRI over 1 year in patients with asthma and/or COPD
2023-09-09
Lung physiology and 129Xe MRI data driven clustering of patients with asthma and/or COPD
2023-09-09
Patient-reported symptoms as drivers of COPD exacerbation risk in routine care
2023-09-09
Symptom Burden, Health Status, and Productivity in Patients with Uncontrolled and Controlled Severe Asthma in NOVELTY.
2023-06-1113 citations

24 more papers not shown